Page last updated: 2024-08-26

carbidopa, levodopa drug combination and raclopride

carbidopa, levodopa drug combination has been researched along with raclopride in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brousolle, E; Dentresangle, C; Froment, JC; Guerin, J; Lavenne, F; Le Bars, D; Pierre, C; Pollak, P; Veyre, L1
Abi-Dargham, A; Bailey, V; Brown, PJ; Chen, C; Roose, SP; Rutherford, BR; Slifstein, M; Stern, Y; Valente, E; Vanegas-Arroyave, N; Wall, MW1

Trials

1 trial(s) available for carbidopa, levodopa drug combination and raclopride

ArticleYear
Effects of L-DOPA Monotherapy on Psychomotor Speed and [
    Biological psychiatry, 2019, 08-01, Volume: 86, Issue:3

    Topics: Aged; Aged, 80 and over; Carbidopa; Corpus Striatum; Depressive Disorder, Major; Dopamine; Dopamine Antagonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; New York; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Walking Speed

2019

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and raclopride

ArticleYear
Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6

    Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Tomography, Emission-Computed

1999